CLSA is proud that hundreds of our innovative member companies call the Bay Area home, and we look forward to working with Mayor-elect London Breed and her Administration to advance thoughtful policies that will grow and ensure the vibrancy of San Francisco’s treasured life sciences ecosystem.
2018 – 2019 state budget includes $30 million for Precision Medicine Research
CLSA Pres & CEO Sara Radcliffe was recently featured in the San Diego Union-Tribune commenting on the entrepreneurial spirit and growth of San Diego’s biomedical sector, which is focused advancing new treatments for patients in need.
Newly introduced legislation bridges Medicare patient access gaps and modernizes policies to allow coverage of medical technologies approved through FDA’s expedited review process
As results from yesterday’s California Primary Elections continue trickling in, the CLSA federal government relations team would like to share a brief update on some anticipated changes in the makeup of our California delegation for the 117th Congress, and offer additional details on several key California congressional races you may be interested in.
As results from yesterday’s California Primary Elections continue trickling in, CLSA’s state government relations team would like to share a brief update on some anticipated changes in the makeup of the California Legislature, and offer additional details on several key California races you may be interested in.
A number of CLSA members pen an op-ed in The Mercury News on the need safeguard the University of California’s critical role in the state’s life sciences business ecosystem.
Report shows that the life science industry continues to be a strong job engine for California; over 85% of companies surveyed indicate plans to add technical employees in the next year, particularly in R&D, Quality and Regulatory Affairs/Compliance.
California Life Sciences Association (CLSA) today announced a new Chair and the addition of a new member to its Board of Directors. William J. Newell, Chief Executive Officer of Sutro Biopharma, Inc., transitioned from Vice Chair to Chair of the Board. Jared L. Watkin, Senior Vice President, Diabetes Care, Abbott, has joined the Board of Directors. In addition, Melinda Richter, Global Head, Johnson & Johnson Innovation, JLABS, formerly CLSA’s Treasurer, was appointed as the new Vice Chair of the organization.
CLSA President & CEO Sara Radcliffe pens an op-ed in the San Diego Business Journal regarding the need to nurture California and San Diego’s innovative life sciences industry.